6th Drug Formulation, Solubility & Bioavailability – 6th Drug Formulation, Solubility & Bioavailability
Most of the drugs and APIs currently on the market are poorly water-soluble and need to have their bioavailability improved through the development of enabled formulations and patient-centric delivery mechanisms. Despite the promises of many “next generation” techniques, the biopharma industry continues to rely on refinements to amorphous solid dispersions and hot melt extrusions. Formulation professionals will continue to face challenges in the solubility and characterization of these drug delivery methods for years to come.
Now in its sixth year, the Drug Formulation, Solubility & Bioavailability conference is geared toward improving drug performance and therapeutic impact through enabled formulations and more effective delivery methods.
Top Five Reasons to Attend
Optimal techniques to increase dose loading in early stages when little drug material is available
Special emphasis on how to select the ideal excipients for both small molecules and biologics
A road map for improving drug characterization techniques without getting swamped by an overabundance of data
In-depth insights on the latest advances in subcutaneous, inhalation, oral and ocular drug delivery technologies
An unprecedented focus on the development and solubility improvement of amorphous solid dispersions
Who Should Attend
This conference is designed for pharmaceutical, biotech and medical device professionals responsible for the following areas: